Skip to content
PIL Logo

Zantac 75 Tablets

Last Updated on eMC 03-May-2016 View changes  | Omega Pharma Ltd Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Text only version for the visually impaired
Below is a text only representation of the Patient Information leaflet. The original may contain images or tables and can be viewed in PDF format using the link to the left. This PIL may be available from the RNIB in large print, Braille or audio CD. For further information please call the RNIB Medicine Leaflet line on 0800 198 5000. The product code(s) for this leaflet is/are: PL02855/0082 .



Zantac 75 Tablets

PATIENT INFORMATION LEAFLET

Zantac 75®

Ranitidine Hydrochloride 75 mg

Please read right through this leaflet before you start using this medicine. This medicine is available without prescription, but you still need to use Zantac 75 carefully to get the best results from it.

  • Keep this leaflet, you may need to read it again.
  • If you have any questions, or if there is anything you do not understand, ask your pharmacist.

In this leaflet:

1. What Zantac 75 does
2. Check before you take Zantac 75
3. How to take Zantac 75
4. Possible side effects
5. How to store Zantac 75
6. Further information

1. What Zantac 75 does

Zantac 75 is used to treat and prevent indigestion and heartburn for up to 12 hours. The stomach produces acid which helps to digest food. Sometimes your stomach produces too much acid which can cause indigestion and heartburn.

The active ingredient is ranitidine hydrochloride which is a medicine called an ‘H2-blocker’. It works by preventing your stomach from producing too much acid.

2. Check before you take Zantac 75

Do not take Zantac 75:

  • if you have ever had an allergic reaction to ranitidine or to any of the other ingredients (listed in Section 6)
  • if you are under 16 years.

Ask your doctor before you take this medicine:

  • if you have kidney or liver problems
  • if you have porphyria (too much of the pigment called porphyrin which may discolour the urine)
  • if you have unintended weight loss associated with acid indigestion
  • if you are middle-aged or older with new or recently changed indigestion symptoms
  • if you have persistent stomach pain
  • if you are under regular medical supervision
  • if you are elderly
  • if you have breathing problems
  • if you have a weak immune system
  • if you suffer from diabetes.

If you are taking other medicines

Talk to your doctor or pharmacist before taking Zantac 75 if you are taking any other medicines, including those obtained without a prescription; particularly medicines to prevent blood clotting, such as warfarin, medicines for insomnia (e.g. triazolam, midazolam), medicines for lowering blood glucose (e.g. glipizide), medicines for fungal infections (e.g. ketoconazole, itraconazole, posaconazole), medicines for treating HIV infection (e.g. atazanavir, delavirdine), medicines for lung cancer (e.g. gefitnib) and non-steroidal anti-inflammatory painkillers (e.g. aspirin or ibuprofen). This advice is even more important if you are elderly.

Pregnancy and breast feeding

Talk to your doctor before taking Zantac 75 if you are pregnant, trying to become pregnant or are breast feeding.

3. How to take Zantac 75

Adults and children aged 16 years and over:

Swallow 1 tablet, with a drink of water, as soon as you have symptoms.

If symptoms persist for more than one hour or return, take another tablet.

To prevent your symptoms, you can take 1 tablet half an hour to an hour before eating or drinking.

  • Do not take more than 4 tablets in 24 hours.
  • Do not take for longer than 2 weeks at a time.
  • Do not take more than the recommended dose.

If you take too many tablets

Contact your doctor or casualty department.

4. Possible side effects

Like all medicines, Zantac 75 can have side effects, but they are rare:

Stop taking the medicine and tell your doctor immediately if you experience:

  • Allergic reactions. These are very rare but may include developing an itchy rash, swelling of the eyelids, face or lips (with or without a lumpy skin rash elsewhere on the body), unexplained fever, difficulty breathing, dizziness (especially on standing up) and chest pain or tightness.
  • Unexplained bruising or bleeding, sore throat, mouth ulcers, fever, extreme paleness, weakness or exhaustion. These can be signs of blood disorders such as anaemia, low white blood cells, low platelet count, suppressed bone marrow or reduction in agranulocytes (a type of white blood cell).

The following side effects may occur. Tell your doctor if you get them.

  • Confusion, depression, drowsiness or hallucinations.
  • Headache, dizziness or sudden, jerky movements.
  • Changes in heart rhythm.
  • Inflammation of your blood vessels.
  • Sudden inflammation of your pancreas (you may get severe stomach pain) or diarrhoea.
  • Stomach pain, constipation, feeling sick (nausea).
  • Inflammation of your liver which may cause one or more of the following: feeling or being sick, fever, itching, yellowing of the skin and eyes, dark coloured urine. This can cause changes to your liver function tests.
  • Hair loss, blurred vision.
  • Aches and pains in your muscles and joints.
  • Sudden inflammation of your kidneys.
  • Increase of serum creatine in the blood (kidney function test).
  • Blood in your urine or changes in the normal amount of urine.
  • Impotence.
  • Swollen, tender or leaking breasts.

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Zantac 75

Store below 25°C. Tablets should not be removed from blisters until immediately prior to use.

Keep out of the reach and sight of children.

Do not use this medicine after the ‘EXP’ date shown on the pack.

6. Further information

Active ingredients Each tablet contains Ranitidine Hydrochloride 84 mg (equivalent to Ranitidine 75 mg).

Other ingredients Microcrystalline cellulose, magnesium stearate, hypromellose (E 464), titanium dioxide (E 171), red iron oxide (E 172) and triacetin.

Packs of Zantac 75 contain 24 and 48 tablets.

The marketing authorisation holder is

Omega Pharma Ltd.
32 Vauxhall Bridge Road
London
SW1V 2SA
United Kingdom

and all enquiries should be sent this address.

Manufactured by:

Glaxo Wellcome SA
Aranda de Duero
Burgos
Spain

or

Omega Pharma International
Venecoweg 26
B-9810 Nazareth
Belgium

or

Famar ltalia
S.p.A Via Zambeletti
25 20021
Baranzate (Ml)
ITALY

Zantac is a registered trademark of the GlaxoSmithKline group of companies and is used under licence.

This leaflet was revised in March 2016.

LF03528C 2623701 / IS-150-152-60B2

Company contact details

Omega Pharma Ltd

Company image
Address

Omega Pharma Ltd, 1st Floor, 32 Vauxhall Bridge Road, London, SW1V 2SA, UK

Medical Information e-mail
Telephone

+44 (0)203 598 9603

Customer Care direct line

+44 (0)1748 828 860

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

ranitidine hydrochloride

Legal categories

P - Pharmacy

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue